News

Daniel Bravo Andreu Private Foundation awards a grant to Carles Diez to continue cutting-edge research in cardiology

The Daniel Bravo Andreu Private Foundation has awarded its grants for biomedical research stays at benchmark centres abroad to PhD candidate Carles Diez of Bellvitge University Hospital–Bellvitge Biomedical Research Institute (IDIBELL)

Leer más about Daniel Bravo Andreu Private Foundation awards a grant to Carles Diez to continue cutting-edge research in cardiology

The solidarity campaign “Elles contra l’ELA” kicks off

The “Elles contra ELA” solidarity campaign begins today with the aim of raising awareness about ALS and raising funds for research. This project is promoted by the research group on neurological and neurogenetic diseases of the Bellvitge Biomedical Research Institute (IDIBELL), with the support of the Catalan Foundation of ALS Miquel Valls, the sponsorship of […]

Leer más about The solidarity campaign “Elles contra l’ELA” kicks off

A new system expands the gene-editing possibilities in animals

This new CRISPR-Cas9 tool can modify gene sites that were inaccessible until now, which bypasses the limited capabilities of gene editing and reinforce precision medicine.

Leer más about A new system expands the gene-editing possibilities in animals

Begins the exchange program between IDIBELL and SZBL

It begins the selection of candidates to carry out a doctoral program in Regenerative Medicine between the SZBL and the IDIBELL. The program will run mainly at SZBL and will have a minimum six months stay at IDIBELL.

Leer más about Begins the exchange program between IDIBELL and SZBL

SARS-CoV-2 vaccines are safe and effective in people with immunodeficiency

The analysis show that these vaccines are safe and able to generate immunity in three out of four patients with immune system defects from birth, and in almost all patients treated with immunosuppressants who were evaluated in the study.

Leer más about SARS-CoV-2 vaccines are safe and effective in people with immunodeficiency

A clinical trial shows the safety and potential of an oncolytic virus against advanced pancreatic cancer

Preliminary results show that the virus is active, reaches the primary tumor and metastases, and triggers the immune system response. In addition, at recommended doses, it has no important adverse effects.

Leer más about A clinical trial shows the safety and potential of an oncolytic virus against advanced pancreatic cancer

Psychosocial factors determine the effectiveness of self-care in patients with heart failure

Lack of family and social support and depressive symptoms are the main factors that impair patients’ ability to adopt healthy habits and practices.

Leer más about Psychosocial factors determine the effectiveness of self-care in patients with heart failure

The second edition of the project “VacunAcció: how to immunize yourself against misinformation” concludes

The initiative, promoted by the Escolab program and carried out by IDIBELL, has been carried out with 4th year ESO students from the Escola Pia of Granollers.

Leer más about The second edition of the project “VacunAcció: how to immunize yourself against misinformation” concludes
Scroll to Top